Penserra Capital Management LLC 2seventy Bio, Inc. Transaction History

Penserra Capital Management LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 15, 2023	BUY	$3.14 - $11.2 $37,218 - $132,753	11,853 Added 126.92%	21,192 $83,000
Q2 2023 Aug 11, 2023	BUY	$8.45 - $12.48 $6,836 - $10,096	809 Added 9.48%	9,339 $94,000
Q1 2023 Apr 24, 2023	BUY	$9.21 - $14.98 $1,934 - $3,145	210 Added 2.52%	8,530 $87,000
Q4 2022 Feb 13, 2023	SELL	$8.57 - $17.0 $66,520 - $131,954	-7,762 Reduced 48.27%	8,320 $77,000
Q3 2022 Nov 14, 2022	BUY	$12.56 - $17.54 $157,427 - $219,846	12,534 Added 353.27%	16,082 $233,000
Q2 2022 Aug 15, 2022	BUY	$10.55 - $18.81 $37,431 - $66,737	3,548 New	3,548 $46,000

126

45.6M

122K

19.8K

Ticker TSVT
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 37,873,600
Market Cap $113M
Description
2seventy bio, Inc., a cell and gene therapy company, focuses on the research, development, and commercialization of treatments for cancer in the United States. Its products pipeline includes idecabtagene vicleucel; ide-cel or Abecma and bb21217; and CAR-T cell product candidates for the treatment of multiple myeloma. 2seventy bio, Inc. has a col...

Get notified when there are updates to the investment portfolio of Penserra Capital Management LLC, based on Form 13F filings with the SEC.

Stay updated on Penserra Capital Management LLC with notifications on news.